Cyclophosphamide (UK) – Patient Information

Cyclophosphamide is a chemotherapy medicine used to treat certain cancers and some immune-related conditions. It works by interfering with DNA in rapidly dividing cells. Because it can cause serious side effects, treatment is usually planned and monitored closely by specialist clinicians.

This page provides patient-friendly information about how cyclophosphamide works, how it is used, key safety points, and practical guidance for living with treatment in the United Kingdom.

Product overview

How cyclophosphamide works (mechanism of action)

Cyclophosphamide is a prodrug. After it enters the body, it is activated mainly in the liver to form compounds that damage DNA. These active metabolites “alkylate” DNA, leading to:

• DNA cross-linking, which blocks DNA replication and cell division
• Cell death particularly in fast-growing cells (e.g., cancer cells and some immune cells)
• Immunosuppressive effects that reduce abnormal immune activity in certain diseases

In cancer therapy, cyclophosphamide may be used alone or as part of combination regimens. In immune-related conditions, it may be used to control severe inflammatory disease.

Pharmacokinetics (what the body does to the drug)

Pharmacokinetics describes how a medicine is absorbed, processed, and eliminated. For cyclophosphamide, the key points include:

• Absorption: When taken by mouth, cyclophosphamide is absorbed variably; food can influence absorption rates.
• Activation: The liver converts cyclophosphamide into active metabolites.
• Distribution: Active forms distribute through body tissues, including bone marrow and lymphoid tissues.
• Elimination: Metabolites are removed largely through the kidneys into urine.
• Urinary toxic effects: Because metabolites are excreted in urine, there is a known risk of bladder irritation and bleeding.

Clinicians often monitor blood and urine parameters to manage these risks promptly.

Typical uses and indications (what it’s used for)

Cyclophosphamide is used in multiple specialist settings. The exact indication and regimen depend on diagnosis and treatment goals.

Oncology (cancer)

• Some lymphomas and related blood cancers
• Multiple myeloma regimens (commonly as part of combination protocols, depending on patient factors)
• Breast cancer regimens (e.g., certain adjuvant or metastatic combinations)
• Ovarian cancer and other gynaecological cancers in selected protocols
• Some leukaemias as part of combination chemotherapy
• Other cancers where an oncologist judges it appropriate

Immune-related conditions (immunosuppression)

• Severe autoimmune disease in cases where benefits outweigh risks
• Examples may include certain vasculitis and severe inflammatory conditions (exact eligibility depends on clinical criteria and guidelines)

Important: The specific use and dose depend on the diagnosis, treatment protocol, kidney and liver function, and overall blood counts.

How and when cyclophosphamide is taken (timing and regimen)

How you take cyclophosphamide depends on the prescribed regimen. Common patterns include:

• Oral tablets: usually taken in a schedule over days or weeks, often with breaks between courses.
• Intravenous or injection use: given in hospital or day-case settings at planned intervals.

Timing tips:

• Take oral cyclophosphamide at the same times each day as directed.
• If you miss a dose, do not double up to compensate. Seek advice from your clinical team or pharmacist.
• Because cyclophosphamide is a cytotoxic medicine, tablets should be handled with care (see “Practical use tips”).

Your treatment plan may be adjusted based on side effects and blood test results.

Food interactions and lifestyle considerations

Food interactions can affect the absorption of some medicines. With cyclophosphamide, practical guidance often includes:

• General advice: Follow your clinician’s or pharmacist’s instructions about whether to take with food or on an empty stomach.
• Consistency matters: If your team advises a particular approach (with food or without), keeping that approach consistent day-to-day helps maintain more predictable exposure.

Always check: Your brand of cyclophosphamide, your dosage form (tablet vs injection), and your regimen may influence specific advice. If you are unsure, ask your pharmacist.

Alcohol and medicine interactions

Alcohol

Alcohol may increase strain on the liver and can worsen certain side effects such as nausea or tiredness. Because cyclophosphamide can also affect the liver and bone marrow, it is generally recommended to:

• Limit or avoid alcohol during treatment unless your clinician says otherwise.

Medicine interactions

Many medicines can interact with cyclophosphamide, either by affecting liver enzymes or by compounding side effects such as low blood counts or bleeding risk. Tell your healthcare team about:

• All prescription medicines
• Over-the-counter products (including cold/flu remedies)
• Herbal supplements and “natural” remedies
• Vaccines planned during treatment

Examples of important interaction areas:

• Other medicines that suppress the immune system may increase infection risk.
• Medicines that affect blood clotting may increase bleeding risk, especially if platelets drop.
• Liver enzyme inducers/inhibitors may change cyclophosphamide activation and effectiveness/toxicity.
• Drugs that also irritate the bladder can potentially add to urinary toxicity.

Because interaction risk is individual, your pharmacist can screen your specific list for clinically significant issues.

Dosing (what you can expect)

Cyclophosphamide dosing is highly individual. It is calculated based on factors such as:

• Diagnosis and treatment protocol
• Body surface area (BSA) for many chemotherapy regimens
• Age and general health
• Kidney and liver function
• Baseline blood counts
• Previous treatment history

Dose schedules differ widely. Some regimens are given in cycles (e.g., days of treatment followed by rest periods), while others may be weekly or daily for defined periods.

Do not change your dose or stop early without medical advice. Cyclophosphamide dosing may need careful adjustment based on blood test results and toxicity.

Safety profile and side effects

Cyclophosphamide can cause side effects, some of which can be serious. Many side effects are manageable with prompt assessment, dose adjustments, or supportive medicines.

Common side effects

• Low white blood cell count (neutropenia/leukopenia): increased risk of infection
• Anaemia: tiredness, weakness, shortness of breath
• Low platelets (thrombocytopenia): easier bruising or bleeding
• Nausea and vomiting
• Hair thinning or hair loss (depends on regimen and dose)
• Fatigue
• Loss of appetite
• Changes to fertility (may be temporary or permanent depending on dose and individual factors)
• Bladder irritation (see “Urinary toxicity” below)

Serious risks to be aware of

• Infection: Contact urgent medical services if you develop fever or feel significantly unwell, especially during periods of low white blood cells.
• Haemorrhagic cystitis (bladder inflammation with bleeding): may present with blood in urine, burning when passing urine, urgency, or pelvic pain.
• Secondary cancers: a small long-term risk exists with certain chemotherapy agents.
• Effects on the heart or lungs: less common but important; symptoms may include breathlessness, chest pain, or unusual swelling.
• Liver or kidney effects: unusual liver enzyme changes may occur; kidney function is monitored.
• Severe allergic reactions: rare, but possible.

Urinary toxicity and protective measures

Because metabolites are excreted in urine, cyclophosphamide can irritate the bladder. Your specialist may recommend protective steps such as:

• Hydration: drinking adequate fluids (as advised) to help dilute urine
• Regular urine passing: avoid holding urine for long periods
• Specific protective medicines may be used in some regimens to reduce bladder toxicity (your team will guide you)

Practical use tips for patients

These tips are designed to help you use cyclophosphamide safely and reduce day-to-day risks. Follow your clinical team’s advice for your specific regimen.

Handling oral tablets

• Wear gloves if your instructions require them and handle tablets carefully.
• Do not crush or break tablets unless your pharmacist advises it is permitted for your specific product.
• If a tablet is spilled, follow the instructions given by your treatment centre for safe disposal and cleaning.
• Keep tablets out of reach of children.

During treatment

• Attend all blood test appointments to monitor blood counts and organ function.
• Report symptoms early rather than waiting, particularly fever, infections, mouth ulcers, unusual bruising/bleeding, or urinary symptoms.
• Maintain hydration unless you have fluid restrictions due to other medical conditions.
• Practice good hygiene and follow infection-prevention advice from your care team.
• Discuss contraception and fertility preservation with your team before starting treatment.

When to seek urgent help

Seek urgent medical advice immediately if you experience:

• Fever (often defined by your team; commonly 38°C or higher)
• Chills, severe sore throat, or signs of infection
• Blood in urine, painful urination, severe pelvic pain
• Shortness of breath, chest pain, or fainting
• Severe bleeding or black/tarry stools
• Severe allergic symptoms (swelling, wheezing, collapse)

Alternative options

Alternative treatments depend on the underlying disease (cancer type, stage, and goals of care) or the specific immune condition. In many protocols, cyclophosphamide may be compared with other chemotherapy or immunosuppressive medicines.

Possible alternatives (examples) may include:

• Other alkylating agents used in chemotherapy regimens (chosen by oncology specialists)
• Different chemotherapy classes (e.g., antimetabolites, anthracyclines, taxanes) depending on the cancer
• Other immunosuppressants/biologics for immune-related conditions (selected based on severity, organ involvement, and response)

Discuss options with your clinician. Your best alternative depends on effectiveness, your comorbidities, and expected side effects.

UK market and legal context (general information)

In the United Kingdom, cyclophosphamide is regulated as a medicinal product. Chemotherapy medicines are subject to strict quality and safety requirements, including prescribing and dispensing practices within the NHS and private healthcare settings.

Key points relevant to the UK:

• Specialist use: Cyclophosphamide is typically administered and managed by oncology or specialist services.
• Safety controls: Cytotoxic medicines are handled and stored under controlled conditions to protect patients and healthcare staff.
• Monitoring: Treatment involves scheduled blood tests and clinical assessments.
• Pharmacovigilance: Suspected side effects should be reported to support ongoing safety monitoring in the UK.

In addition to national safety frameworks, UK guidance is shaped by medicines regulatory authorities and professional bodies. Local NHS pathways and cancer networks may influence regimen selection and supportive care.

Recent guidance and healthcare developments (high-level)

In recent years, cancer care in the UK has continued to emphasise:

• Risk-adapted supportive care for infections and blood-count suppression
• Improved monitoring schedules for treatment safety
• Fertility and long-term health counselling before starting cytotoxic therapy
• Individualised treatment decisions based on patient fitness, comorbidities, and biomarker-driven care where applicable

Because treatment protocols change, your specialist team may recommend additional supportive medications (for example, anti-sickness medicines or infection prevention strategies) based on current best practice for your diagnosis and regimen.

Delivery and availability (UK)

Availability of cyclophosphamide products can vary by supplier, dosage, and whether it is provided as oral tablets or via hospital administration.

How delivery often works for chemotherapy tablets via UK online pharmacies:

• Stock availability depends on your specific strength and formulation.
• Orders may require identity and medication-safety checks in line with UK pharmacy regulations and standard practice.
• Packaging typically includes protective labelling suitable for cytotoxic medicines.
• Dispatch timelines vary; delivery can be affected by supplier lead times and prescription/dispensing workflow in the UK healthcare system.

Cold chain requirements: Cyclophosphamide does not typically require refrigeration, but always follow storage instructions on the pack.

If a product is temporarily unavailable, your pharmacy may offer an alternative strength/formulation or advise on delivery times.

FAQ

Is cyclophosphamide the same as “chemo”?

Yes. Cyclophosphamide is a chemotherapy medicine (a cytotoxic alkylating agent) and is also used in some immune-related conditions due to its immunosuppressive effects. It is commonly referred to as chemotherapy in cancer care.

How long does treatment take?

It depends on your diagnosis and treatment plan. Some regimens are given over a limited number of cycles, while others follow a longer schedule. Your clinician will explain the planned duration and course intervals.

What blood tests will I need?

Most people require regular monitoring of blood counts (white cells, haemoglobin, platelets) and sometimes liver and kidney function. This helps detect side effects early and guide dose adjustments.

Can I get vaccinated while on cyclophosphamide?

Vaccination advice during chemotherapy must be individualised. In general, live vaccines may be avoided during immunosuppression. Speak to your specialist team or pharmacist before any vaccination.

Can I continue normal activities?

Many people can do light daily activities, but fatigue is common. Plan rest periods and avoid strenuous activities if you feel unwell or if your blood counts are low. Follow infection-prevention advice for your situation.

What should I do if I feel unwell between appointments?

Contact your clinic or urgent medical service if you have symptoms such as fever, chills, unusual bruising/bleeding, severe vomiting, or urinary symptoms (pain, urgency, blood). Do not wait for the next scheduled appointment.

Does cyclophosphamide affect fertility?

It may. Fertility can be affected temporarily or permanently depending on dose and individual factors. Fertility preservation options should be discussed before starting treatment where possible.

How should I store cyclophosphamide tablets?

Store the medicine according to the instructions on the pack, usually at room temperature away from moisture and heat. Keep it secured and out of sight and reach of children.

Are there long-term risks?

Like many chemotherapy agents, cyclophosphamide can carry long-term risks. Your clinician will discuss benefits versus risks for your individual situation and will arrange follow-up as appropriate.

Important: This information is for general patient guidance. Your regimen, supportive medicines, and monitoring may differ. Always follow the instructions provided by your healthcare team and read the patient information leaflet supplied with your specific product.